Anthony Gregg Lapointe - 09 Jun 2022 Form 4/A - Amendment Insider Report for Astria Therapeutics, Inc. (ATXS)

Role: Director
Signature: /s/ Ben Harshbarger, as attorney-in-fact for Gregg Anthony LaPointe
Issuer symbol: ATXS
Transactions as of: 09 Jun 2022
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 21 Jun 2022, 08:32:00 UTC
Date Of Original Report: 09 Jun 2022
Previous filing: 23 May 2022
Next filing: 21 Nov 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATXS	Stock Option (right to buy)	Award	$0	+8,333		$0.000000	8,333	09 Jun 2022	Common Stock	8,333	$3.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being made to show the correct price of $3.00. An incorrect price of $2.99 was previously reported.
F2	This option was granted on June 9, 2022 and will vest in its entirety on the one-year anniversary of the grant date, subject to the director's continued service.